Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Cambrian Bio Appoints Health Policy Veteran Adrienne Hallett as Vice President of Global Policy and Strategic Initiatives
Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging, […]
CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs
CHARM Therapeutics, a 3D deep learning biotechnology company discovering and developing transformational medicines, today announced […]
Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
Karuna Therapeutics, a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people […]
Azafaros Appoints Chief Operating Officer and Head of Finance
Azafaros today announced two appointments to their executive management team with Silvia Ragno, PhD, joining […]
Investigational Oral Osteoarthritis Drug APPA May Have a Promising Senotherapeutic Effect with Potential in Other Diseases of Ageing
New data presented at the 2023 Osteoarthritis Research Society International (OARSI) World Congress in Denver, […]
Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo
Incyte has announced new data from a Phase 2b clinical trial evaluating the safety and […]
Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata
Concert Pharmaceuticals, a company recently acquired by Sun Pharmaceutical, has announced the presentation of data […]
RVAC Medicines Announces Research Collaboration with University of Pennsylvania
RVAC Medicines, a messenger RNA (mRNA) technology company with its global headquarters in Singapore, has […]
Hackensack Meridian Health Invests $14 Million Into Oncology Expansion at JFK University Medical Center
Hackensack Meridian Health is proud to announce it is investing $14 million dollars at JFK […]
China's First Personalized Neoantigen-Targeted Cancer Vaccine Receives NMPA's Clinical Trial Approval
According to the latest data released in the Clinical Trials Implied Approval section on the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more